CLEARVIEW WEALTH LIMITED — Fund Information / Factsheet 2008

Feb 6, 2008

==> picture [595 x 87] intentionally omitted <==

==> picture [595 x 87] intentionally omitted <==

COMPANY ANNOUNCEMENT

Date: 7th February, 2008

MMC’s Contrarian Global Value Fund

In accordance with listing rule 3.17 we attach the letter that was sent to all shareholders in relation to MMC Asset Management’s Contrarian Global Value Fund.

For further information please contact:

Brian Wright Company Secretary. MMC Contrarian Limited (+612) 9224 0700

About MMC Contrarian Limited

MMC Contrarian Ltd (ASX listing code: MMA) is a listed financial services company that:

• Creates and invests in unlisted boutique fund managers in various asset classes;

• Acquires strategic stakes in existing funds management business; and

• Generates income for shareholders from two sources (a) returns on a pool of listed equities, cash and funds that are managed by its investee companies and (b) recurring earnings from each manager that it creates or acquires.

==> picture [595 x 87] intentionally omitted <==

==> picture [595 x 87] intentionally omitted <==

Special Offer – MMC’s Contrarian Global Value Fund

As communicated to the ASX on the 9[th] of July 2007, MMC Asset Management Limited ( MMC ) launched the Contrarian Global Value Fund ( the Fund ). The Fund was seeded with $20m and opened on 9 July 2007.

As a shareholder of MMC Contrarian we are pleased to inform you of an offer by MMC to you or a family member of the opportunity to participate in the Fund by reducing the minimum investment amount of $25,000 to $10,000.

This letter provides some further background on the Fund from MMC for your information.

About the Fund

• MMC has appointed Contrarian Global Asset Management Limited ( CGAM ), an Edinburgh based “long only” global equities boutique fund manager, to provide investment advisory services to assist MMC manage the Fund.

• The Fund’s objective is to maximise long term capital appreciation and capital preservation by providing investors with a concentrated portfolio of international equities, bonds and cash that aims to achieve a rate of return in excess of the Morgan Stanley Capital International ( MSCI ) All Countries World ex Australia index (unhedged) in $A over rolling three year time frames; however this is not guaranteed.

• The Fund aims to achieve this objective by opportunistically selecting stocks from around the globe, with a high degree of flexibility. The Fund may hold cash when there is a lack of suitable investments that meet the Fund's strict valuation criteria.

• CGAM's research approach is opportunistic and indifferent to sectors, industries, market capitalisation, countries and benchmarks. CGAM is not attempting to cover every company in the world but to identify and concentrate on those relative few that meet its stringent valuation criteria.

• The Fund’s investment style is ‘absolute value’.

• The CGAM investment team of Charles L. Heenan CFA, and Geoff Legg M.Sc., AIA, is based in Edinburgh, the home of some of the leading global fund managers. Further details on the CGAM investment team is contained in the Contrarian Global Value Fund Product Disclosure Statement and/or you can visit the CGAM website at www.contrarianam.co.uk.

==> picture [595 x 87] intentionally omitted <==

==> picture [595 x 87] intentionally omitted <==

Top 8 stocks as 31 December 2007

	Stock	Country	Industry	Market Cap ($US)	Fund Weighting
1.	Johnson & Johnson	USA	Medical Products	188,417m	6.66%
2.	Lerado	Hong Kong	Baby Products	70m	6.09%
3.	Tradelink	Hong Kong	E-Commerce	101m	4.79%
4.	AsiaSat	Hong Kong	Satellite Transmission	749m	4.67%
5.	Gold Bullion	NA	Commodity	NA	4.35%
6.	Munich Re	Germany	Financial Services	41,904m	4.34%
7.	GlaxoSmithKline	UK	Pharmaceuticals	139,358m	4.30%
8.	MobileOne	Singapore	Cellular Telecom	1,175m	4.26%
	Other	Various	Various	NA	26.02%
Cash				NA	34.52%

Further information, including the Fund’s Product Disclosure Statement, thought leadership papers and an introductory presentation can be downloaded at www.contrarianam.co.uk. A direct investment in the Fund can only be made using an application form attached to the Product Disclosure Statement.

If you would like to discuss the Fund in more detail, please contact MMC on 02 9224 0700.

Kind Regards Andrew Fairweather

Chief Executive Officer MMC Contrarian Limited

The information contained in this letter is general information only and does not take into account an individual’s financial objectives, financial situation or needs. Before making an investment in the Fund, individuals need to consider the product disclosure statement for the Fund (“PDS”) and whether the Fund is appropriate in light of their own circumstances. MMC Asset Management Limited (“MMC) makes no representation as to the performance of the Fund, the maintenance of capital or any particular rate of return. MMC does not guarantee the performance of the Fund or the repayment of capital invested. This letter is not to be taken as advice being given by MMC to invest into the Fund. MMC is the issuer of units in the Fund. The PDS is available from MMC by contacting MMC on 02 9224 0700 or downloading a copy from CGAM’s website at www.contrarianam.co.uk.

Information about fees and costs payable to MMC and other persons in respect of the Fund is set out in the PDS.